Immutep Ltd banner

Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.05 AUD -1.96% Market Closed
Market Cap: AU$73.7m

Immutep Ltd
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Immutep Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Immutep Ltd
ASX:IMM
Goodwill
AU$110k
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Mesoblast Ltd
ASX:MSB
Goodwill
$134.5m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
CSL Ltd
ASX:CSL
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Race Oncology Ltd
ASX:RAC
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Goodwill
AU$199m
CAGR 3-Years
230%
CAGR 5-Years
116%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Immutep Ltd
Glance View

Market Cap
73.7m AUD
Industry
Biotechnology

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. The company is headquartered in Sydney, New South Wales. The firm is engaged in the development of LAG-3 immunotherapeutic products for cancer and autoimmune disease. The firm has four product candidates based on the LAG-3 immune control mechanism. Its lead product candidate, eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein, which is in later-stage clinical development for the treatment of cancer. Its second product candidate (IMP761) is in pre-clinical development for the treatment of autoimmune disease. The Company’s two licensed product candidates include Antagonist AB (LAG525) and Depleting AB (GSK‘781). The Company’s operates through its subsidiaries, which includes Immutep USA Inc, PRR Middle East FZ LLC, Immutep GmbH, Immutep Australia Pty Ltd, Immutep IP Pty Ltd and Immutep S.A.S.

IMM Intrinsic Value
0.39 AUD
Undervaluation 87%
Intrinsic Value
Price

See Also

What is Immutep Ltd's Goodwill?
Goodwill
110k AUD

Based on the financial report for Dec 31, 2025, Immutep Ltd's Goodwill amounts to 110k AUD.

What is Immutep Ltd's Goodwill growth rate?
Goodwill CAGR 10Y
0%

Over the last year, the Goodwill growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett